Anúncio
Anúncio
BBIO
BridgeBio Pharma, Inc. Common Stock
74.26
USDPatrocinado
+0.27
+0.36%
07 de jan., 16:00 UTC -5
Encerrado
Pós-Mercado
74.25
-0.01
-0.01%
Relatórios de Lucros BBIO
Rácio de surpresa positiva
BBIO separação 8 de 26 últimas estimativas.
31%
Próximo Relatório
Data do Próximo Relatório
18 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$144.68M
/-$0.75
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+19.87%
/-21.05%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+2359.73%
/-46.43%
BridgeBio Pharma, Inc. Common Stock earnings per share and revenue
On 29 de out. de 2025, BBIO reported earnings of -0.95 USD per share (EPS) for Q3 25, missing the estimate of -0.90 USD, resulting in a -4.81% surprise. Revenue reached 120.70 milhão, compared to an expected 108.51 milhão, with a 11.23% difference. The market reacted with a -4.88% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -0.75 USD, with revenue projected to reach 144.68 milhão USD, implying an diminuir of -21.05% EPS, and aumentar of 19.87% in Revenue from the last quarter.
FAQ
What were BridgeBio Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, BridgeBio Pharma, Inc. Common Stock reported EPS of -$0.95, missing estimates by -4.81%, and revenue of $120.70M, 11.23% above expectations.
How did the market react to BridgeBio Pharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.88%, changed from $66.62 before the earnings release to $63.37 the day after.
When is BridgeBio Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for 18 de fev. de 2026.
What are the forecasts for BridgeBio Pharma, Inc. Common Stock's next earnings report?
Based on 17
analistas, BridgeBio Pharma, Inc. Common Stock is expected to report EPS of -$0.75 and revenue of $144.68M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio